Work

In paired cultures of colorectal liver metastases, higher TPD52 expression tracks a stronger response to volasertib

Year: 2026
Type: preprint
Abstract: Among pairs of tumors grown in the lab from the same patient, the tumor with more activity of a gene called TPD52 was usually more sensitive to volasertib. The link stood out in a search across thousands of genes, but the data could not tell whether it was particular to volasertib or reflected sensitivity to several drugs. It cannot guide a patient's choice of treatment. The top gene–drug hit in paired colorectal liver metastasis cultures, TPD52–volasertib, did not distinguish drug-specific from broader sensitivity. After subtraction of each pair's typical difference on the other drugs, the hit retained 78% of its score, compared with 73% on average for winners of shuffled searches. Neither the remaining score nor TPD52's association with mean panel sensitivity stood out against the corresponding shuffled searches. Additional lesions gave mixed results. Finding published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/metastasis-tpd52-volasertib/v1/
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7237364943
Cites:
Cited by:
Related to: